Wegovy now comes in two forms: a once-weekly injection (semaglutide 2.4 mg) and, since the FDA approved it on December 22, 2025, a once-daily pill (oral semaglutide 25 mg). Both contain semaglutide….
Side-by-side GLP-1 comparisons: Wegovy vs Zepbound, semaglutide vs tirzepatide, pills vs injections and the leading online programs, with costs, results and trade-offs explained in plain English.
Topic hub · 38 guides
Side-by-side GLP-1 comparisons: Wegovy vs Zepbound, semaglutide vs tirzepatide, pills vs injections and the leading online programs, with costs, results and trade-offs explained in plain English.
Compare GLP-1 programsGLP-1 questions answeredCost calculator
Wegovy now comes in two forms: a once-weekly injection (semaglutide 2.4 mg) and, since the FDA approved it on December 22, 2025, a once-daily pill (oral semaglutide 25 mg). Both contain semaglutide….
Many online GLP-1 programs charge a monthly membership on top of the medication, which can add $100 to $150 a month to your bill. If you want to avoid that, there are…
Zepbound and compounded tirzepatide contain the same active ingredient, but they are not the same product. Zepbound is made by Eli Lilly and approved by the FDA. Compounded tirzepatide is prepared by…
By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianSemaglutide sodium and semaglutide acetate are salt forms, and they are not the active ingredient in…
By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianThe difference is oversight. A 503A pharmacy compounds for individual patients against individual prescriptions and is…
By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianTirzepatide has an approved indication for moderate-to-severe obstructive sleep apnea in adults with obesity, which is…
By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianThe SELECT trial studied semaglutide in adults with established cardiovascular disease and overweight or obesity, without…
By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianPrediabetes is not an approved indication for any GLP-1 medication. Where these drugs are used in…
By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianOrforglipron is an investigational oral GLP-1 receptor agonist in a different chemical class from the peptide…
By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianRetatrutide is an investigational compound that acts on three receptor pathways rather than tirzepatide’s two. Trial…